Jaguar Health, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Mailing Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
Phone
415-371-8300
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 9, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 8-K Current report of material events | February 18, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 10, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
Material Events
8-K
Financial Distress
March 6, 2026
High Impact
- Jaguar Health received a delisting warning from Nasdaq on March 5, 2026, for failing to meet the $1.00 minimum bid price.
- The company does not qualify for the standard 180-day grace period due to significant reverse stock splits (1-for-250 or greater) within the past two years.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.